🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ksenia Blinova

United States Food and Drug Administration

ORCID: 0000-0003-1123-3152

Also affiliated with Center for Drug Evaluation and Research, Food and Drug Administration

NeuroscienceMedicineBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study”.

Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study

Frontiers in Drug Discovery(2025)10.3389/fddsv.2025.1679626

N/A

0.104DataRank · unranked

1 citations

Carlos J. Serna, Bhavya Bhardwaj, Tromondae K. Feaster, Ksenia Blinova, Robert Geiger

Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee

Journal of Pharmacological and Toxicological Methods(2024)10.1016/j.vascn.2024.107511

N/A

0DataRank · unranked

2 citations

Brian R. Berridge, Ksenia Blinova, Marjory B. Brooks, Sandy Eldridge, Claire E. O’Brien +7 more

Nonclinical human neural new approach methodologies (NAMs): Electrophysiological assessment of opioid agonist and antagonist combination

NAM journal.(2025)10.1016/j.namjnl.2025.100064

N/A

0DataRank · unranked

0 citations

Bhavya Bhardwaj, Tromondae K. Feaster, Ksenia Blinova, Carlos J. Serna